NCT06368466View on ClinicalTrials.gov

A Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Sites

NACompletedINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

July 5, 2024

Study Completion Date

December 19, 2024

Conditions
Hepatitis BHepatitis B Infection
Interventions
DEVICE

iStatis HBsAg Test

capillary (fingerstick) blood, EDTA venous whole blood, serum and plasma samples are tested on the iStatis HBsAg Test

Trial Locations (1)

3065

St. Vincent's Hospital, Melbourne, Melbourne

Sponsors
All Listed Sponsors
collaborator

St Vincent's Hospital Melbourne

OTHER

lead

bioLytical Laboratories

INDUSTRY

NCT06368466 - A Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Sites | Biotech Hunter | Biotech Hunter